Catalyst Pharmaceuticals, Inc. (CPRX)
24.06
-0.29
(-1.19%)
USD |
NASDAQ |
Dec 29, 16:00
24.06
0.00 (0.00%)
Pre-Market: 20:00
Catalyst Pharmaceuticals Total Liabilities (Quarterly): 131.36M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | 1.333B |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Amicus Therapeutics, Inc. | 638.39M |
| Rigel Pharmaceuticals, Inc. | 124.92M |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.052B |
| Shareholders Equity (Quarterly) | 920.24M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 6.622 |
| Net Debt Paydown Yield | 0.00% |